Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Dr Mathew Iype
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults aged equal and above 18 years. 2. Patients undergoing PCI with implantation of the Evermine 50 stent. 3.Patient has given written informed consent for participation prior to enrolment. 4.Patient is willing to undergo all study procedures and follow-up requirements.
Exclusion criteria
Exclusion criteria: 1. Hypersensitivity or allergy to aspirin, heparin, clopidogrel ticlopidine drug such as Everolimus or similar drugs or any analogue or derivative cobalt chromium nickel molybdenum tungsten or any contrast media. 2. Patientin whom antiplatelet and or anticoagulant therapy are contraindicated. 3. Life expectancy of less than 1 year due to non-cardiac comorbidities. 4. Pregnant or lactating females. 5. Any condition that in the opinion of the Investigator would preclude safe participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Target Lesion FailureTimepoint: 1 Year | — |
Secondary
| Measure | Time frame |
|---|---|
| Target Lesion Failure (TLF)Timepoint: 30 days 6 months;Cardiovascular deathTimepoint: 30 days, 6 months, 1 year;Target Vessel Myocardial InfarctionTimepoint: 30 days, 6 months, 1 year;Clinically-Driven TLR (CD-TLR)Timepoint: 30 days, 6 months, 1 year;Stent Thrombosis (ST) RateTimepoint: 30 days, 6 months, 1 year;Target Vessel Revascularization (TVR)Timepoint: 30 days, 6 months, 1 year;Target Vessel Failure (TVF)Timepoint: 30 days, 6 months, 1 year;Device successTimepoint: Index Procedure;Procedure successTimepoint: Discharge | — |
Countries
India
Contacts
Public ContactMathew Iype
Medical College Hospital, Trivandrum
Outcome results
None listed